Monitor H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues
Monitor Public Law 117-328, Consolidated Appropriations Act, FY2023, Cancer related issues
Monitor the following:
Cancer Moonshot related issues
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues
H.R.5585, ARPA-H Act, Entirety
H.R.7667, Food and Drug Amendments of 2022, Entirety
S.4348, FDASLA Act of 2022, Diagnostic Test related issues
H.R.6000, CURES 2.0, generally
Public Law 117-328, Consolidated Appropriations Act, FY2023, Cancer related issues
Monitor CMS Reimbursement
Duration: January 1, 2008
to
December 31, 2022
General Issues: Budget/Appropriations , Health Issues , Medicare/Medicaid
Spending: about $1,840,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, Office of Science & Technology Policy (OSTP), House of Representatives, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of the Vice President of the United States, Defense Advanced Research Projects Agency (DARPA), Natl Science Foundation (NSF), Office of Management & Budget (OMB), U.S. Senate,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Edward Long, PhD Staff Director, Sen Approp Subcomm Labor/HHS and Education
Staff Director,SenAppropSubcomm Labor/HHS/Ed
Staff Director,Sen Approp Subcomm Labor/HHS/Ed
Edward Long, PhD (cont.) Legislative Director, Senator Tom Harkin
Legislative Director, Senator Brock Adams
Legislative Assistant, Senator Tom Harkin
Katherine Vanlandingham LegAsst/Correspondence Director, Senator Sam Brownback
LegAsst/CorrespDir, Senator Sam Brownback
Edward Long, PhD (COP cont.) Legislative Director, Senator Tom Harkin
Legislative Director, Senator Brock Adams
Legislative Assistant, Senator Tom Harkin
Jennifer LaTourette Chief of Staff, Congressman Steven LaTourette; Special Assistant/Senior Legislative Assistant/Scheduler, Congressman Robert Borski; and Press Intern/Deputy Finance Director, Senator Max Baucus
Jessica Malow n/a
H. Stewart Van Scoyoc n/a
Jessica Molesworth n/a
Jessica Molesworth (Formerly Malow) n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2022
Van Scoyoc Associates terminated an engagement in which they represented Dana Farber Cancer Institute on Jan. 18, 2023.
Original Filing: 301431792.xml
Lobbying Issues
Monitor H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues
Monitor Public Law 117-328, Consolidated Appropriations Act, FY2023, Cancer related issues
Lobbying Issues
Monitor the following:
Cancer Moonshot related issues
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues
H.R.5585, ARPA-H Act, Entirety
H.R.7667, Food and Drug Amendments of 2022, Entirety
S.4348, FDASLA Act of 2022, Diagnostic Test related issues
H.R.6000, CURES 2.0, generally
Public Law 117-328, Consolidated Appropriations Act, FY2023, Cancer related issues
Lobbying Issues
Monitor CMS Reimbursement
3rd Quarter, 2022
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 19, 2022.
Original Filing: 301409839.xml
Lobbying Issues
Monitor H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues
Lobbying Issues
Cancer Moonshot related issues
Monitor the following:
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues
H.R.5585, ARPA-H Act, Entirety
H.R.7667, Food and Drug Amendments of 2022, Entirety
S.4348, FDASLA Act of 2022, Diagnostic Test related issues
H.R.6000, CURES 2.0, generally
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor CMS Reimbursement
2nd Quarter, 2022
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 19, 2022.
Original Filing: 301384572.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues
H.R.5585, ARPA-H Act, Entirety
H.R.7667, Food and Drug Amendments of 2022, Entirety
S.4348, FDASLA Act of 2022, Diagnostic Test related issues
Monitor the following:
H.R.708/S.168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
H.R.5376, Build Back Better Act, Hospital related issues
H.R.6000, CURES 2.0, generally
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor CMS Reimbursement
1st Quarter, 2022
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 19, 2022.
Original Filing: 301362291.xml
Lobbying Issues
Cancer research related issues; and Workforce health issues, as follows:
H.R.4502/S.3062, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022
Public Law 117-103, Consolidated Appropriations Act, FY2022
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4502/S.3062, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Cancer research related issues; and Workforce health issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues
Monitor the following:
H.R.708/S.168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
H.R.5376, Build Back Better Act, Hospital related issues
H.R.6000, CURES 2.0, generally
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor CMS Reimbursement
4th Quarter, 2021
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Jan. 19, 2022.
Original Filing: 301327121.xml
Lobbying Issues
H.R.4502/S.3062, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Cancer research related issues; and Workforce health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4502/S.3062, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Cancer research related issues; and Workforce health issues
Monitor the following:
H.R.708/S.168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
H.R.5376, Build Back Better Act, Hospital related issues
H.R.6000, CURES 2.0, generally
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor CMS Reimbursement
3rd Quarter, 2021
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 19, 2021.
Original Filing: 301305062.xml
Lobbying Issues
H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Cancer research related issues; and Workforce health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Build Back Better Act, Hospital related issues
Cancer research related issues; and Workforce health issues, as follows:
H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022
H.R.708/S.168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor CMS Reimbursement
2nd Quarter, 2021
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 19, 2021.
Original Filing: 301279900.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Cancer research related issues; and Workforce health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research related issues; and Workforce health issues, as follows:
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY202
H.R.708/S.168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor CMS Reimbursement
1st Quarter, 2021
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 19, 2021.
Original Filing: 301255775.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Cancer research related issues; and Workforce health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research related issues; and Workforce health issues, as follows:
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY202
H.R.708/S.168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor CMS Reimbursement
4th Quarter, 2020
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Jan. 19, 2021.
Original Filing: 301235602.xml
Lobbying Issues
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer research related issues; and Workforce health issues
Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, Cancer research related issues; and Workforce health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer research related issues; and Workforce health issues
Public Law 116-283, William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021, Hospital related issues
S.4421, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
H.R.9049, To amend title XVIII of the Social Security Act to establish a cancer center construction grant program, Entirety
Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, Cancer research related issues; and Workforce health issues; Division BB, Private Health Insurance and Public Health Provisions, Surprise Medical Billing; Monitor Division M Cornavirus Response and Relief Supplemental Appropriations Act, 2021, and Monitor Division N Additional Coronavirus Response and Relief
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor CMS Reimbursement
3rd Quarter, 2020
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 19, 2020.
Original Filing: 301214393.xml
Lobbying Issues
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer research related issues; and Workforce health issues
H.R.8319, Continuing Appropriations, FY2021 and Other Extensions Act
Monitor Cancer research related issues as follows:
Public Law 116-123/H.R.6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020
Public Law 116-127, H.R.6201, Families First Coronavirus Response Act
Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act
H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer research related issues; and Workforce health issues
H.R.6395/S.4049, William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021, Hospital related issues
S.4421, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
Monitor Cancer research related issues as follows:
Public Law 116-123/H.R.6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020
Public Law 116-127, H.R.6201, Families First Coronavirus Response Act
Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act
H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor CMS Reimbursement
2nd Quarter, 2020
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 17, 2020.
Original Filing: 301191855.xml
Lobbying Issues
Cancer research and related issues; and Workforce health issues, as follows:
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021
Public Law 116-123/H.R.6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020
Public Law 116-127, H.R.6201, Families First Coronavirus Response Act
Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act
H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations
Lobbying Issues
Monitor CMS Reimbursement
1st Quarter, 2020
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 17, 2020.
Original Filing: 301169072.xml
Lobbying Issues
Cancer research and related issues; and Workforce health issues, as follows:
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021
Public Law 116-123/H.R.6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020
Public Law 116-127, H.R.6201, Families First Coronavirus Response Act
Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108215.xml
Lobbying Issues
Cancer research and related issues; and Worker health issues, as follows:
Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division A -- Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020
Public Law 116-59, Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
Public Law 116-69, Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 18, 2019.
Original Filing: 301069265.xml
Lobbying Issues
Cancer research and related issues; and Worker health issues, as follows:
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
H.R.4378, Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
Public Law 116-37, Bipartisan Budget Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer Moonshot Initiative
Precision Medicine Initiative
Cancer research and related issues; and Worker health issues, as follows:
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 19, 2019.
Original Filing: 301050106.xml
Lobbying Issues
Cancer research and related issues; and Worker health issues, as follows:
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer Moonshot Initiative
Precision Medicine Initiative
S.1895, A bill to lower health care costs, generally
Surprise Medical Billing, generally
Cancer research and related issues; and Worker health issues, as follows:
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2019
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 19, 2019.
Original Filing: 301030257.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer Moonshot Initiative
Precision Medicine Initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Jan. 18, 2019.
Original Filing: 301009189.xml
Lobbying Issues
Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer Moonshot Initiative
Precision Medicine Initiative
Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2018
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 19, 2018.
Original Filing: 300991924.xml
Lobbying Issues
H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Big data issues
Cancer Moonshot Initiative
Precision Medicine Initiative
H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2018
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 19, 2018.
Original Filing: 300969777.xml
Lobbying Issues
S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, Cancer research and related issues; and Worker health issues
H.R.6157/S.3159, Department of Defense Appropriations Act, FY2019, Cancer research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Big data issues
Cancer Moonshot Initiative
Precision Medicine Initiative
S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2018
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 19, 2018.
Original Filing: 300948382.xml
Lobbying Issues
Cancer research and related issues; and Worker health issues, as follows:
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019
Public Law 115-141, Consolidated Appropriations Act, FY2018
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer and medical research issues
Big data issues
Cancer Moonshot Initiative
Precision Medicine Initiative
Public Law 115-141, Consolidated Appropriations Act, FY2018, generally
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2017
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Jan. 22, 2018.
Original Filing: 300932340.xml
Lobbying Issues
Cancer research and related issues; and Worker health issues, as follows:
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018
Public Law 115-56, Continuing Appropriations Act, FY2018 and Supplemental Appropriations for Disaster Relief Requirements Act, FY2017
H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, FY2018
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018
Public Law 115-90, Making further continuing appropriations for fiscal year 2018, and for other purposes
Public Law 115-96, Further Additional Continuing Appropriations Act, FY2018
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer and medical research issues
Big data issues
Cancer Moonshot Initiative
Precision Medicine Initiative
Public Law 115-91, National Defense Authorization Act for Fiscal Year 2018, Medical research provisions
Public Law 115-97, An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018, Track
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2017
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 20, 2017.
Original Filing: 300911163.xml
Lobbying Issues
Cancer research and related issues; and Worker health issues, as follows:
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018
Public Law 115-56, Continuing Appropriations Act, FY2018 and Supplemental Appropriations for Disaster Relief Requirements Act, FY2017
H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, FY2018
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer and medical research issues
Big data issues
Cancer Moonshot Initiative
Precision Medicine Initiative
H.R.1628, American Health Care Act of 2017, Health coverage issues
Better Care Reconciliation Act
H.R.2810/S.1519, National Defense Authorization Act for Fiscal Year 2018, Medical research provisions
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 20, 2017.
Original Filing: 300891794.xml
Lobbying Issues
Cancer research and related issues; and Worker health issues, as follows:
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017
President Trump's 2018 Budget
Public Law 115-30, Making further continuing appropriations for fiscal year 2017, and for other purposes
Public Law 115-31, Consolidated Appropriations Act, FY2017
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer and medical research issues
Public Law 114-255, 21st Century Cures Act, Implementation
Big data issues
Cancer Moonshot Initiative
Precision Medicine Initiative
H.R.1628, American Health Care Act of 2017, Health coverage issues
Better Care Reconciliation Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 114-255, 21st Century Cures Act, Implementation
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2017
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 19, 2017.
Original Filing: 300871517.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017 and FY2018, Cancer research and related issues; and Worker health issues
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017
President Trump's 2018 Budget Blueprint
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer and medical research issues
Public Law 114-255, 21st Century Cures Act, Implementation
Big data issues
Cancer Moonshot Initiative
Precision Medicine Initiative
H.R.1628, American Health Care Act of 2017, Health coverage issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 114-255, 21st Century Cures Act, Implementation
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2016
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Jan. 20, 2017.
Original Filing: 300852737.xml
Lobbying Issues
H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, Cancer research and related issues; and Worker health issues
Public Law 114-223, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2017, and Zika Response and Preparedness Act
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer and medical research issues
H.R.6, 21st Century Cures Act
H.R.34, 21st Century Cures Act
Big data issues
Cancer Moonshot Initiative
Precision Medicine Initiative
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5273, Helping Hospitals Improve Patient Care Act of 2016, generally
H.R.34, 21st Century Cures Act, Reimbursement issues
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2016
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 19, 2016.
Original Filing: 300831495.xml
Lobbying Issues
H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, Cancer research and related issues; and Worker health issues
H.R.5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2017, and Zika Response and Preparedness Act, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer and medical research issues
H.R.6, 21st Century Cures Act
Biomedical innovation legislation (Senate draft)
Big data issues
H.R.4273/S.2409, Medicare and Medicaid Improvements and Adjustments Act of 2015, Medicare reimbursement issues
Cancer Moonshot Initiative
Precision Medicine Initiative
S.2624, National Biomedical Research Act
S.320, Medical Innovation Act of 2015
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2895, Medicare Patient Access to Cancer Treatment Act of 2015, generally
H.R.3291, Medicare Crosswalk Hospital Code Development Act of 2015, generally
H.R.3292, Medicare IME Pool Act of 2015, generally
H.R.3288, Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015, generally
H.R.4273/S.2409, Medicare and Medicaid Improvements and Adjustments Act of 2015, Medicare reimbursement issues
H.R.5273, Helping Hospitals Improve Patient Care Act of 2016, generally
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2016
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 19, 2016.
Original Filing: 300812785.xml
Lobbying Issues
S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, Cancer research and related issues; and Worker health issues
Public Law 114-74, Bipartisan Budget Act of 2015, Medicare reimbursement
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research issues
H.R.6, 21st Century Cures Act, Medical research issues
Big data issues
H.R.4273/S.2409, Medicare and Medicaid Improvements and Adjustments Act of 2015, Medicare reimbursement issues
Cancer Moonshot Initiative
Precision Medicine
S.2624, National Biomedical Research Act
S.320, Medical Innovation Act of 2015
S. 2030, The Advancing Targeted Therapies for Rare Diseases Act of 2015
S. 1622, The FDA Device Accountability Act of 2015
S. 2014, Next Generation Researchers Act
S. 800, The Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act
S. 849, Advancing Research for Neurological Diseases Act of 2015
S. 2503, Preventing Superbugs and Protecting Patients Act
S. 2511, Improving Health Information Technology
S. 1878, The Advancing Hope Act of 2015
S. 1077, The Advancing Breakthrough Medical Devices for Patients Act of 2015
S. 1101, The Medical Electronic Data Technology Enhancement for Consumers Health Act
S. 2055, The Medical Countermeasures Innovation Act of 2015
S. 1767, The Combination Products Innovation Act of 2015
S. 1597, Patient Focused Impact Assessment Act of 2015
S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act
S. 2700, FDA and NIH Workforce Authorities Modernization Act
S. 185, Promise for Antibiotics and Therapeutics for Health Act
S. 2713, Advancing Precision Medicine Act of 2016
S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act
S. 2742, Promoting Biomedical Research and Public Health for Patients Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor the following:
H.R.2895, Medicare Patient Access to Cancer Treatment Act of 2015, generally
H.R.3291, Medicare Crosswalk Hospital Code Development Act of 2015, generally
H.R.3292, Medicare IME Pool Act of 2015, generally
H.R.3288, Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015, generally
H.R.4273/S.2409, Medicare and Medicaid Improvements and Adjustments Act of 2015, Medicare reimbursement issues
H.R.5273, Helping Hospitals Improve Patient Care Act of 2016, generally
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2016
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 19, 2016.
Original Filing: 300796487.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, Cancer research and related issues; and Worker health issues
Public Law 114-74, Bipartisan Budget Act of 2015, Medicare reimbursement
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research issues
H.R.6, 21st Century Cures Act, Medical research issues
Big data issues
H.R.4273/S.2409, Medicare and Medicaid Improvements and Adjustments Act of 2015, Medicare reimbursement issues
Cancer Moonshot Initiative
Precision Medicine
S.2624, National Biomedical Research Act
S.320, Medical Innovation Act of 2015
S. 2030, The Advancing Targeted Therapies for Rare Diseases Act of 2015
S. 1622, The FDA Device Accountability Act of 2015
S. 2014, Next Generation Researchers Act
S. 800, The Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act
S. 849, Advancing Research for Neurological Diseases Act of 2015
S. 2503, Preventing Superbugs and Protecting Patients Act
S. 2511, Improving Health Information Technology
S. 1878, The Advancing Hope Act of 2015
S. 1077, The Advancing Breakthrough Medical Devices for Patients Act of 2015
S. 1101, The Medical Electronic Data Technology Enhancement for Consumers Health Act
S. 2055, The Medical Countermeasures Innovation Act of 2015
S. 1767, The Combination Products Innovation Act of 2015
S. 1597, Patient Focused Impact Assessment Act of 2015
S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act
S. 2700, FDA and NIH Workforce Authorities Modernization Act
S. 185, Promise for Antibiotics and Therapeutics for Health Act
S. 2713, Advancing Precision Medicine Act of 2016
S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act
S. 2742, Promoting Biomedical Research and Public Health for Patients Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor the following:
H.R.2895, Medicare Patient Access to Cancer Treatment Act of 2015, generally
H.R.3291, Medicare Crosswalk Hospital Code Development Act of 2015, generally
H.R.3292, Medicare IME Pool Act of 2015, generally
H.R.3288, Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015, generally
H.R.4273/S.2409, Medicare and Medicaid Improvements and Adjustments Act of 2015, Medicare reimbursement issues
4th Quarter, 2015
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Jan. 19, 2016.
Original Filing: 300774519.xml
Lobbying Issues
H.R.3020/S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, Cancer research and related issues; and Worker health issues
Public Law No: 114-53, Continuing Appropriations Act, FY2016, Cancer research and related issues; and Worker health issues
H.R.2250, Further Continuing Appropriations Act, FY2016, Cancer research and related issues; and Worker health issues
Public Law 114-74, Bipartisan Budget Act of 2015, Medicare reimbursement
Public Law No. 114-113, Consolidated Appropriations Act, FY2016, Cancer research and related issues; Worker health issues; and Medicare reimbursement
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research issues
H.R.6, 21st Century Cures Act, Medical research issues
Big data issues
Public Law No. 114-113, Consolidated Appropriations Act, FY2016, Medicare reimbursement
H.R.4273/S.2409, Medicare and Medicaid Improvements and Adjustments Act of 2015, Medicare reimbursement issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor the following:
H.R.2895, Medicare Patient Access to Cancer Treatment Act of 2015, generally
H.R.3291, Medicare Crosswalk Hospital Code Development Act of 2015, generally
H.R.3292, Medicare IME Pool Act of 2015, generally
H.R.3288, Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015, generally
H.R.4273/S.2409, Medicare and Medicaid Improvements and Adjustments Act of 2015, Medicare reimbursement issues
3rd Quarter, 2015
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 17, 2015.
Original Filing: 300755930.xml
Lobbying Issues
H.R.3020/S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, Cancer research and related issues; and Worker health issues
Public Law No: 114-53, Continuing Appropriations Act, FY2016, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research issues
H.R.6, 21st Century Cures Act, Medical research issues
Big data issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor the following:
H.R.2895, Medicare Patient Access to Cancer Treatment Act of 2015, generally
H.R.3291, Medicare Crosswalk Hospital Code Development Act of 2015, generally
H.R.3292, Medicare IME Pool Act of 2015, generally
H.R.3288, Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015, generally
2nd Quarter, 2015
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 17, 2015.
Original Filing: 300737572.xml
Lobbying Issues
S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research issues
Public Law 114-10, Medicare Access and CHIP Reauthorization Act of 2015, Hospital reimbursement issues
H.R.6, 21st Century Cures Act, Medical research issues
Big data issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 114-10, Medicare Access and CHIP Reauthorization Act of 2015, Hospital reimbursement issues
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2015
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 17, 2015.
Original Filing: 300717914.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, Cancer research and related issues; and Worker health issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research issues
Public Law 113-93, Protecting Access to Medicare Act of 2014, Hospital reimbursement
issues
H.R.2, Medicare Access and CHIP Reauthorization Act of 2015, Hospital reimbursement issues
Big data issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 113-93, Protecting Access to Medicare Act of 2014, Hospital reimbursement issues
H.R.2, Medicare Access and CHIP Reauthorization Act of 2015, Hospital reimbursement issues
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2014
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Jan. 19, 2015.
Original Filing: 300700543.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, Cancer research and related issues.
Public Law 113-164, Continuing Appropriations Resolution, FY2015, Cancer research and related issues.
Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015, Cancer research and related issues.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 111-148, Patient Protection and Affordable Care Act, Implementation issues.
Cancer research issues
Public Law 113-93, Protecting Access to Medicare Act of 2014, Hospital reimbursement issues
Big data issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 113-93, Protecting Access to Medicare Act of 2014, Hospital reimbursement issues
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 16, 2014.
Original Filing: 300677399.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, Cancer research and related issues.
Public Law 113-164, Continuing Appropriations Resolution, FY2015, Cancer research and related issues.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 111-148, Patient Protection and Affordable Care Act, Implementation issues.
Cancer research issues
Public Law 113-93, Protecting Access to Medicare Act of 2014, Hospital reimbursement issues
Big data issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 113-93, Protecting Access to Medicare Act of 2014, Hospital reimbursement issues
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 16, 2014.
Original Filing: 300657654.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, Cancer research and related issues.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 111-148, Patient Protection and Affordable Care Act, Implementation issues.
Cancer research issues
Public Law 113-93, Protecting Access to Medicare Act of 2014, Hospital reimbursement issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 113-93, Protecting Access to Medicare Act of 2014, Hospital reimbursement issues
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 18, 2014.
Original Filing: 300640539.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, Cancer research and related issues.
Public Law 113-46, Continuing Appropriations Act, FY2014, generally
Public Law 113-73, Making further continuing appropriations for fiscal year 2014, and for other purposes, generally
Public Law 113-76, Consolidated Appropriations Act, FY2014, generally
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 111-148, Patient Protection and Affordable Care Act, Implementation issues.
Cancer research issues
H.R.4302, Protecting Access to Medicare Act of 2014, Hospital reimbursement issues
S.1871, SGR Repeal and Medicare Beneficiary Access Act of 2013, Hospital reimbursement issues
H.R.2810, Medicare Patient Access & Quality Improvement Act of 2013, generally
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4302, Protecting Access to Medicare Act of 2014, Hospital reimbursement issues
S.1871, SGR Repeal and Medicare Beneficiary Access Act of 2013, Hospital reimbursement issues
H.R.2810, Medicare Patient Access & Quality Improvement Act of 2013, generally
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Jan. 17, 2014.
Original Filing: 300617337.xml
Lobbying Issues
S.1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, Cancer research and related issues.
H.J.Res.59, Continuing Appropriations Resolution, FY2014, generally
Public Law 113-46, Continuing Appropriations Act, FY2014, generally
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 111-148, Patient Protection and Affordable Care Act, Implementation issues.
Cancer research issues
Monitor the following:
The Sustainable Growth Rate (SGR) Repeal and Medicare Beneficiary Access Improvement Act of 2013
H.R.2810, Medicare Patient Access & Quality Improvement Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Bone Marrow transplantation research and development program issues
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on Oct. 19, 2013.
Original Filing: 300601088.xml
Lobbying Issues
S.1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, Cancer research and related issues.
H.J.Res.59, Continuing Appropriations Resolution, FY2014, generally
Agencies Lobbied
Natl Institutes of Health (NIH)
Lobbying Issues
Public Law 111-148, Patient Protection and Affordable Care Act, Implementation issues.
Cancer research issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Bone Marrow transplantation research and development program issues
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on July 18, 2013.
Original Filing: 300574980.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, Cancer research and related issues.
Agencies Lobbied
Natl Institutes of Health (NIH)
Lobbying Issues
Public Law 111-148, Patient Protection and Affordable Care Act, Implementation issues.
Cancer research issues
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 20, 2013.
Original Filing: 300558089.xml
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, Cancer research and related issues.
Public Law 112-25, Budget Control Act of 2011, Cancer research and related issues.
Public Law 112-175, Continuing Appropriations Resolution, FY2013, Cancer research and related issues; Sequestration implementation issue
Public Law 113-6, Consolidated and Further Continuing Appropriations Act, FY2013, Cancer research and related issues.
Public Law 112-240, American Taxpayer Relief Act of 2012, Cancer research and related issues.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, Cancer research and related issues.
Monitor the following:
H.Con.Res.25,Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 (House Concurrent Resolution)
S.Con.Res.8, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023 (Senate Concurrent Resolution)
Agencies Lobbied
Natl Institutes of Health (NIH)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $20,000. The report was filed on Jan. 21, 2013.
Original Filing: 300536914.xml
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, Cancer research and related issues.
Public Law 112-25, Budget Control Act of 2011, Cancer research and related issues.
H.J.Res.117, Continuing Appropriations Resolution, FY2013,Cancer research and related issues;Sequestration implementation issueH.R. 8, American Taxpayer Relief Act of 2012, Cancer research and related issues.
Lobbying Issues
H.R.733/S.362, Recalcitrant Cancer Research Act of 2012, Cancer research issues.
H.R.4310/S.3254, National Defense Authorization Act for Fiscal Year 2013, Cancer research issues.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $10,000. The report was filed on Oct. 17, 2012.
Original Filing: 300508147.xml
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, Cancer research and related issues.
Public Law 112-25, Budget Control Act of 2011, Cancer research and related issues.
H.J.Res.117, Continuing Appropriations Resolution, FY2013,Cancer research and related issues;Sequestration implementation issue
Agencies Lobbied
Office of Management & Budget (OMB)
Lobbying Issues
H.R.733/S.362, Recalcitrant Cancer Research Act of 2012, Cancer research issues.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
Van Scoyoc Associates filed a lobbying registration on Aug. 20, 2012 to represent Dana Farber Cancer Institute, effective Aug. 1, 2012.
Original Filing: 300501999.xml
Issue(s) they said they’d lobby about: Health care policy and appropriations regarding cancer research and treatment issues. .
4th Quarter, 2011
Van Scoyoc Associates terminated an engagement in which they represented Dana Farber Cancer Institute on Jan. 18, 2012.
Original Filing: 300439763.xml
Lobbying Issues
S.1253/H.R.1540, National Defense Authorization Act for Fiscal Year 2012, Cancer research and treatment issues and initiatives.
Public Law 112-74, Consolidated Appropriations Act, FY2012, Cancer research and treatment issues and initiatives.
H.R.2219, Department of Defense Appropriations Act, FY2012, Cancer research and treatment issues and initiatives.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on Oct. 19, 2011.
Original Filing: 300418826.xml
Lobbying Issues
S.1253/H.R.1540, National Defense Authorization Act for Fiscal Year 2012, Cancer research and treatment issues and initiatives.
H.R.2219, Department of Defense Appropriations Act, FY2012, Cancer research and treatment issues and initiatives.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research and treatment programs; Cancer research equipment; and Comprehensive cancer related issues.
2nd Quarter, 2011
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on July 18, 2011.
Original Filing: 300392076.xml
Lobbying Issues
S.1253, National Defense Authorization Act for Fiscal Year 2012, Cancer research and treatment issues and initiatives.
Department of Defense Appropriations Act, FY2013, Cancer research and treatment issues and initiatives.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research and treatment programs; Cancer research equipment; and Comprehensive cancer related issues.
1st Quarter, 2011
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 19, 2011.
Original Filing: 300369028.xml
Lobbying Issues
Cancer research and treatment issues and initiatives.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research and treatment programs; Cancer research equipment; and Comprehensive cancer related issues.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on Jan. 17, 2011.
Original Filing: 300339528.xml
Lobbying Issues
Cancer research and treatment issues and initiatives.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research and treatment programs; Cancer research equipment; and Comprehensive cancer related issues.
3rd Quarter, 2010
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on Oct. 19, 2010.
Original Filing: 300317295.xml
Lobbying Issues
S.3800, Department of Defense Appropriations, FY2011, Cancer research and treatment.
S.3686, Departments of Labor, Health and Human Services, and Education,and Related Agencies Appropriations Act, FY2011, Cancer research and treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research and treatment programs; Cancer research equipment; and Comprehensive cancer related issues.
2nd Quarter, 2010
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on July 16, 2010.
Original Filing: 300288375.xml
Lobbying Issues
Department of Defense Appropriations, FY2011, Cancer research and treatment.
Departments of Labor, Health and Human Services, and Education,and Related Agencies Appropriations Act, FY2011, Cancer research and treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; Cancer research equipment; comprehensive cancer related issues; and End of Life Care issues.
1st Quarter, 2010
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 16, 2010.
Original Filing: 300259815.xml
Lobbying Issues
Department of Defense Appropriations, FY2011, Cancer research and treatment.
Departments of Labor, Health and Human Services, and Education,and Related Agencies Appropriations Act, FY2011, Cancer research and treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; Cancer research equipment; comprehensive cancer related issues; and End of Life Care issues.
4th Quarter, 2009
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on Jan. 18, 2010.
Original Filing: 300234115.xml
Lobbying Issues
H.R.3326, Department of Defense Appropriations, FY2010, Cancer research and treatment.
H.R.3293, Departments of Labor, Health and Human Services, and Education,and Related Agencies Appropriations Act, FY2010, Cancer research and treatment.
H.R.3183/S.1436, Energy and Water Development and Related Agencies Appropriations Act, FY2010, Cancer research equipment.H.R.3288, Consolidated Appropriations Act, FY2010, Cancer research and treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; Cancer research equipment; and comprehensive cancer related issues; and End of Life Care issues.
3rd Quarter, 2009
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on Oct. 15, 2009.
Original Filing: 300205279.xml
Lobbying Issues
H.R.3326, Department of Defense Appropriations, FY2010, Cancer research and treatment.
H.R.3293, Departments of Labor, Health and Human Services, and Education,and Related Agencies Appropriations Act, FY2010, Cancer research and treatment.
H.R.3183/S.1436, Energy and Water Development and Related Agencies Appropriations Act, FY2010, Cancer research equipment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; Cancer research equipment; and comprehensive cancer related issues; and End of Life Care issues.
S.1150, Advance Planning and Compassionate Care Act of 2009, End of Life Care issues.
2nd Quarter, 2009
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on July 11, 2009.
Original Filing: 300175073.xml
Lobbying Issues
Department of Defense Appropriations, FY2010, Cancer research and treatment.
Departments of Labor, Health and Human Services, and Education,and Related Agencies Appropriations Act, FY2010, Cancer research and treatment.
Energy and Water Development and Related Agencies Appropriations Act, FY2010, Cancer research equipment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; Cancer research equipment; and comprehensive cancer related issues; and End of Life Care issues.
S.1150, Advance Planning and Compassionate Care Act of 2009, End of Life Care issues.
1st Quarter, 2009
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $30,000. The report was filed on April 14, 2009.
Original Filing: 300147537.xml
Lobbying Issues
Department of Defense Appropriations, FY2009, Cancer research and treatment.
S.3230, Departments of Labor, Health and Human Services, and Education,and Related Agencies Appropriations Act, FY2009, Cancer research and treatment.
H.R.1105, Omnibus Appropriations Act, FY2009, Cancer research and treatment.Department of Defense Appropriations, FY2010, Cancer research and treatment.
Departments of Labor, Health and Human Services, and Education,and Related Agencies Appropriations Act, FY2010, Cancer research and treatment.
Energy and Water Development and Related Agencies Appropriations Act, FY2010, Cancer research equipment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; Cancer research equipment; and comprehensive cancer related issues.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on Jan. 14, 2009.
Original Filing: 300118144.xml
Lobbying Issues
Department of Defense Appropriations, FY2009, Cancer research and treatment.
S.3230, Departments of Labor, Health and Human Services, and Education,and Related Agencies Appropriations Act, FY2009, Cancer research and treatment.
PL110-329,Consolidated Security, Disaster Assistance and Continuing Appropriations Act, FY2009, Cancer research and treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; and comprehensive cancer related issues.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on Oct. 12, 2008.
Original Filing: 300090276.xml
Lobbying Issues
Department of Defense Appropriations, FY2009, Cancer research and treatment.
S.3230/H.R. TBD, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2009, Cancer research and treatment.
H.R.2638, Consolidated Security, Disaster Assistance and Continuing Appropriations Act, FY2009, Cancer research and treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; and comprehensive cancer related issues.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on July 15, 2008.
Original Filing: 300065497.xml
Lobbying Issues
Department of Defense Appropriations, FY2009, Cancer research and treatment.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2009, Cancer research and treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; and comprehensive cancer related issues.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, Van Scoyoc Associates lobbied for Dana Farber Cancer Institute , earning $40,000. The report was filed on April 14, 2008.
Original Filing: 300035564.xml
Lobbying Issues
Department of Defense Appropriations, FY2009, Cancer research and treatment.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2009, Cancer research and treatment.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Cancer research and treatment programs; and comprehensive cancer related issues.
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...